Strengthening Primary Healthcare Delivery for Diabetes and Hypertension in Eswatini

Recruiting

Trial ID: NCT04183413

Purpose

The WHO-PEN@Scale project is a three-arm cluster-randomized trial that is investigating the population-level effects of a healthcare reform in Eswatini, which aims to strengthen primary care for diabetes and hypertension. Prior to the reform, healthcare for diabetes and hypertension was mostly provided through physician-led teams in hospital outpatient departments. The healthcare reform aims to strengthen the provision of nurse-led care for diabetes and hypertension in primary healthcare facilities and community health worker-led care for these conditions in the facilities' catchment areas. The reform will broadly be guided by the World Health Organization's "Package of Essential Noncommunicable Disease Interventions for Primary Health Care in Low-Resource Settings" (WHO-PEN). The trial will take place at 84 clusters (a primary healthcare facility and its catchment area) across the country.

Official Title

Strengthening Primary Healthcare Delivery for Diabetes and Hypertension in Eswatini: A Cluster-randomized Trial

Stanford Investigator(s)

Eligibility

Inclusion criteria for the outcome assessment (household survey):

* Residing in one of the selected households
* Age ≥40 years

Exclusion criteria for the outcome assessment (household survey):

* Pregnant
* Inability to provide written informed consent

Intervention(s):

other: DSD

other: CDP

Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305